NeuronScore
Signal quality across funding, news, traction & verificationAbout Imperagen
Imperagen delivers highly improved and production-ready enzyme designs by rapidly retraining problem-specific AI models with real-world data. This closed-loop approach achieves significantly greater enzyme improvements in fewer cycles compared to traditional methods. The company focuses on optimizing enzymes for various applications in medicines, materials, and everyday products.
Funding History
1 round · $6.7M total| Date | Stage | Lead Investors | Amount |
|---|---|---|---|
| May 2026 | Seed | PXN Ventures | $6.7M |
MiRus
70Revolutionizing medicine with safer, more durable implants and less invasive surgeries using proprietary Rhenium-based alloy MoRe®.
Profluent
50Frontier AI models for programmable biology and protein design
Recursion
38Pioneering AI-driven solutions in drug discovery to radically improve lives.
Periodic Labs
35Creating AI scientists and autonomous laboratories to accelerate scientific discovery, starting with physical sciences.
Chai Discovery
35Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.
Anagram Therapeutics
32Developing novel orally delivered enzyme therapeutics engineered for rare and life-threatening malabsorption diseases.
FAQ
How much funding has Imperagen raised?
Imperagen has raised $6.7M across 1 round — most recently a Seed led by PXN Ventures in May 2026.
How much does Imperagen cost?
Imperagen pricing: Enterprise · Contact sales.
Discussion
Sign in to join the discussion.
Sign inExplore more around Imperagen
Contextual paths to related AI startups, deals and rankings.